| Yale University School of Medicine | ||
| City: New Haven | State: CT | |
|
Links:
Commentary:COI_Policy_Final_392010.pdf Professionalism_Progress_Committee.pdf COI.pdf Investigator_COI_in_Research.pdf Yale_Drug_Discovery_Course.pdf Standards_Business_Conduct.pdf PR_Pharm_Ind.pdf Policy_3205.pdf Policy_3201.pdf Policy_2201.pdf Final_YMG_Industry_Interactions_Policy_8-17-2010.pdf Conflict__Consumerism_09.pdf Professionalism_Progress_Committee.pdf Summary: Yale University School of Medicine provides a good policy. Disclosure of financial conflicts of interest to patients is required. Personnel involved in procurement processes are required to disclose significant financial interest. Gifts of insignificant value (such as notepads, key rings) and certain business meals are permitted. The purchasing and formulary committee policy has improved in that individuals who have significant financial interests may not make purchasing decisions. Demographics: On average students spend 80% of their training at Yale-New Haven Hospital, 10% at West Haven VA Hospital and 10% at Bridgeport Hospital. Submitted policies apply to all Yale Medical Group clinical personnel who practice in at these sites. Updates: This institution submitted new policies for the 2012-13 AMSA PharmFree Scorecard. Their grade remains a B. This institution's evaluation was last updated: 4/9/2013. |
||
| Gifts & Meals | ![]() |
Gifts and meals are prohibited for clinical personnel. Other employees may receive gifts of insignificant value or business meals. |
| Consulting relationships | ![]() |
Consulting relationships must be described in a written agreement. Payment must be commensurate with tasks according to fair market value. |
| Industry-funded speaking relationships | ![]() |
Presentation content must be controlled by the clinician without influence by the sponsor. Engagement must be governed by a written agreement. |
| Disclosure | ![]() |
Disclosure of financial conflicts of interest to patients is required. |
| Pharmaceutical samples | ![]() |
Formulary samples may be accepted by clinicians but cannot be sold or used for personal use. Such samples are to be used particularly for patients without financial access to medications. |
| Purchasing & Formularies | ![]() |
"An individual may not participate directly in the negotiation of research agreements, license agreements, equipment purchases or other arrangements between the University and an organization in which the individual has a significant financial interest." |
| Industry Sales Representatives | ![]() |
Industry representatives are permitted on the premises but only by an appointment and in non-patient care areas. Access to patient care areas may be granted but only for training with patient consent. |
| On-campus Education | ![]() |
CME activities must be in accordance to ACCME standards. |
| Attendance at Industry-Sponsored Lectures & Meetings Off-Campus | ![]() |
Industry is prohibited from compensating attendance by clinical personnel at off-site events or providing travel support. |
| Industry Support for Scholarships & Funds for Trainees | ![]() |
Selection of participants must be without industry influence. |
| Medical school curriculum | ![]() |
These materlals adequately address pharmaceutical marketing, financial conflicts of interest and its effects on physician decision-making. |
| Do the policies specify an oversight mechanism? | ![]() |
Various officers were earmarked for individual policies. |
| Are there explicit sanctions for noncompliance? | ![]() |
Sanctions are outlined. |
| Model policy | |
| Good progress toward model policy | |
| No policy, or policy unlikely to have a substantial effect on behavior | |
| Did not report | |
| Policy not relevant to this institution (e.g., does not make purchasing decisions) | |